Project Grant HT94252410145
- This $1,526,245 Project Grant awarded on July 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund the "MITOCHONDRIAL INFLAMMATION SYNAPTIC SYSTEMS IMAGING OF NEUROINJURY (MISSION) FOR MILD REPETITIVE TRAUMATIC BRAIN INJURY" research project at the University of Pittsburgh. The project aims to investigate mechanisms and treatments for mild, repetitive traumatic brain injury through research on mitochondrial...
- The University of Pittsburgh was awarded a $2,347,592 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop 4D OXY-WAVELET MRI as a non-invasive biomarker for assessing brain mitochondrial function in vivo. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $569,851 to the University of Pittsburgh to conduct research on the effectiveness of a traumatic brain injury whole blood test for improving assessment and triage of patients with mild traumatic brain injury in civilian emergency departments. The 4-year project, running from July 1, 2025 to June 30, 2029, aims to generate critical insights on how this novel...
- This federal Project Grant award of $673,197.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the University of Pittsburgh to harmonize and analyze multi-omic data on severe traumatic brain injury. The research aims to transform healthcare for military service members and the broader public by developing innovative medical solutions to address critical health challenges. The project will be...
- The University of Pittsburgh was awarded a $795,001 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year award will fund a research project from September 2022 to August 2025 to interrogate the impact of B cells and tertiary lymphoid structures in melanoma brain metastases. Through this funding, the University of Pittsburgh will investigate medical solutions for the battlefield by supporting applied and advanced...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,699,157.00 to the University of Pittsburgh to evaluate the effectiveness of a traumatic brain injury whole blood test in improving assessment and triage for patients with mild traumatic brain injury presenting to civilian emergency departments. The project aims to generate data to support the clinical application of this diagnostic test, which...
- This Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), provides $2,454,969.00 in funding to the University of Pittsburgh to conduct research on "Biomechanical and Physiological Resilience and Recovery in Load Carriage." The research aims to transform healthcare for military service members and the broader public by advancing biomedical knowledge and developing innovative medical solutions. The award period...
- This $392,119 Project Grant was awarded on September 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Pittsburgh. The grant supports establishing statin/MBV-based therapies for enhancing optic nerve regeneration after traumatic optic neuropathy. The University of Pittsburgh, a major recipient of federal research grants, will leverage its academic expertise and research infrastructure to conduct this basic and...
- The University of Pittsburgh has been awarded a $602,986 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award, effective August 1, 2024 through August 31, 2026, will fund a research project titled "A T CELL-GUIDED APPROACH TO DEVELOP ANTIGEN-SPECIFIC IMMUNOTHERAPIES FOR PEDIATRIC BRAIN TUMORS." This project aims to develop innovative immunotherapies for treating pediatric brain tumors by leveraging the...
- The University of Pittsburgh has been awarded a $747,131 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 10, 2024, supports the development of an Extracorporeal Perfusion System (EPS) for composite tissue regeneration. This research effort aims to advance innovative medical technologies to improve health outcomes for military service members and the broader public. The grant will fund a...
The University of Pittsburgh was awarded a $1,306,281 Project Grant under the Department of the Army's Military Medical Research and Development program (CFDA 12.420) to conduct the "MITOCHONDRIAL INFLAMMATORY SYNAPTIC SYSTEMS IMAGING OF NEUROINJURY (MISSION) FOR MILD REPETITIVE TRAUMATIC BRAIN INJURY" research project. The award began on July 1, 2024 and is scheduled for completion on June 30, 2028. The project aims to study the mechanisms of mitochondrial inflammation and synaptic dysfunction in mild, repetitive traumatic brain injury, with the goal of developing improved diagnostic and treatment approaches for this condition. As a major research university, the University of Pittsburgh has extensive expertise and capabilities in biomedical sciences, making it well-positioned to execute this Department of Defense-funded research initiative addressing a critical military health priority.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.3m | 2/20/24 |